PMC7970680_01
Lung CT on day 1 (before treatment). Ground-glass opacity was observed in both lungs, and some infiltrated shadows were also observed in lower lung.
10.1177_2050313X21991063-fig1.jpg
PMC7970680_01_10.1177_2050313X21991063-fig1.jpg
fig1-2050313X21991063
Laboratory findings at admission are shown in Table 1 and Figure 1: blood tests showed white blood cells in the normal range, but an elevated neutrophil fraction of 83% and a severely elevated C-reactive protein (CRP) level of 19.97 mg/dL.
Clinical course.. CVVHDF: continuous venovenous hemodiafiltration; PMX-DHP: polymyxin B immobilized fiber direct hemoperfusion; IL-6: interleukin-6; TNF-alpha: tumor necrosis factor alpha; CRP: C-reactive protein
10.1177_2050313X21991063-fig2.jpg
PMC7970680_01_10.1177_2050313X21991063-fig2.jpg
fig2-2050313X21991063
Clinical course is shown in Figure 2.
Lung CT on day 30 (after extubation).. Ground-glass opacity was observed in both lungs, although lung shadows were getting better than before treatment.
10.1177_2050313X21991063-fig3.jpg
PMC7970680_01_10.1177_2050313X21991063-fig3.jpg
fig3-2050313X21991063
Lung CT performed after extubation (Figure 3) and at the time of his discharge (Figure 4) showed extensive residual infiltrative shadows.
Lung CT on day 51 (before discharge).. Ground-glass opacity was still observed in both lungs. However, lung shadows were much better than lung CT of after extubation.
10.1177_2050313X21991063-fig4.jpg
PMC7970680_01_10.1177_2050313X21991063-fig4.jpg
fig4-2050313X21991063
Lung CT performed after extubation (Figure 3) and at the time of his discharge (Figure 4) showed extensive residual infiltrative shadows.